The latest thoracic oncology news
The City of Hope® is one of the largest and most advanced cancer research and treatment…
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation…
On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a…
When it comes to cancer metastasis, it takes two to tango. That was one of…
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
New data from landmark analysis presented today report a decreased risk of disease recurrence or…
New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in…
A new study from researchers at Brighton and Sussex Medical School (BSMS), in the UK<…